Slot System
Featured Buckets
Featured Buckets Admin

How do you manage a healthy, asymptomatic, 24-year-old with a positive RPR on a premarital blood test?

Article Type
Changed
Fri, 11/02/2018 - 08:16
Display Headline
How do you manage a healthy, asymptomatic, 24-year-old with a positive RPR on a premarital blood test?
Article PDF
Author and Disclosure Information

Sherif B. Mossad, MD
Department of Infectious Disease, The Cleveland Clinic

Address: Sherif B. Mossad, MD, FACP, FIDSA, Department of Infectious Disease, S32, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Issue
Cleveland Clinic Journal of Medicine - 70(2)
Publications
Topics
Page Number
101-102
Sections
Author and Disclosure Information

Sherif B. Mossad, MD
Department of Infectious Disease, The Cleveland Clinic

Address: Sherif B. Mossad, MD, FACP, FIDSA, Department of Infectious Disease, S32, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Author and Disclosure Information

Sherif B. Mossad, MD
Department of Infectious Disease, The Cleveland Clinic

Address: Sherif B. Mossad, MD, FACP, FIDSA, Department of Infectious Disease, S32, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 70(2)
Issue
Cleveland Clinic Journal of Medicine - 70(2)
Page Number
101-102
Page Number
101-102
Publications
Publications
Topics
Article Type
Display Headline
How do you manage a healthy, asymptomatic, 24-year-old with a positive RPR on a premarital blood test?
Display Headline
How do you manage a healthy, asymptomatic, 24-year-old with a positive RPR on a premarital blood test?
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

What is the appropriate treatment for Dupuytren contracture?

Article Type
Changed
Fri, 11/02/2018 - 08:10
Display Headline
What is the appropriate treatment for Dupuytren contracture?
Article PDF
Author and Disclosure Information

Thomas R. Hunt III, MD
Head, Section of Hand Surgery, Department of Orthopaedic Surgery, The Cleveland Clinic

Address: Thomas R. Hunt III, MD, Section of Hand Surgery, Department of Orthopaedic Surgery, A40, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

This paper discusses treatments that are not approved by the US Food and Drug Administration for the use under discussion.

Issue
Cleveland Clinic Journal of Medicine - 70(2)
Publications
Topics
Page Number
96-97
Sections
Author and Disclosure Information

Thomas R. Hunt III, MD
Head, Section of Hand Surgery, Department of Orthopaedic Surgery, The Cleveland Clinic

Address: Thomas R. Hunt III, MD, Section of Hand Surgery, Department of Orthopaedic Surgery, A40, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

This paper discusses treatments that are not approved by the US Food and Drug Administration for the use under discussion.

Author and Disclosure Information

Thomas R. Hunt III, MD
Head, Section of Hand Surgery, Department of Orthopaedic Surgery, The Cleveland Clinic

Address: Thomas R. Hunt III, MD, Section of Hand Surgery, Department of Orthopaedic Surgery, A40, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

This paper discusses treatments that are not approved by the US Food and Drug Administration for the use under discussion.

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 70(2)
Issue
Cleveland Clinic Journal of Medicine - 70(2)
Page Number
96-97
Page Number
96-97
Publications
Publications
Topics
Article Type
Display Headline
What is the appropriate treatment for Dupuytren contracture?
Display Headline
What is the appropriate treatment for Dupuytren contracture?
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

What are the key issues women face when ending hormone replacement therapy?

Article Type
Changed
Fri, 11/02/2018 - 08:06
Display Headline
What are the key issues women face when ending hormone replacement therapy?
Article PDF
Author and Disclosure Information

Wulf H. Utian, MD, BCH, PhD
Department of Obstetrics and Gynecology, The Cleveland Clinic; Professor Emeritus, Case Western Reserve University; Executive Director, The North American Menopause Society

Address: Wulf H. Utian, MD, Executive Director, The North American Menopause Society, 5900 Landerbrook Drive, Cleveland, OH 44124; e-mail: [email protected]

The author has indicated that he has received research support from the Amylin, 3M, Barr Laboratories, Berlex Laboratories, Bristol-Myers Squibb, Byk Gulden, Eli Lilly, Endeavor Pharmaceuticals, Forest Laboratories, Neurocrine Biosciences, Novartis, Novo Nordisk, Organon, Pharmacia, Procter & Gamble, Pfizer, Roche, Sepracor, Solvay Pharmaceuticals, Wyeth, and Yamanouchi USA corporations and serves as a consultant for the Eli Lilly, Endeavor, Pfizer, Berlex, and Warner corporations.

This paper discusses therapies that are not approved by the US Food and Drug Administration for the use under discussion.

Issue
Cleveland Clinic Journal of Medicine - 70(2)
Publications
Topics
Page Number
93-94
Sections
Author and Disclosure Information

Wulf H. Utian, MD, BCH, PhD
Department of Obstetrics and Gynecology, The Cleveland Clinic; Professor Emeritus, Case Western Reserve University; Executive Director, The North American Menopause Society

Address: Wulf H. Utian, MD, Executive Director, The North American Menopause Society, 5900 Landerbrook Drive, Cleveland, OH 44124; e-mail: [email protected]

The author has indicated that he has received research support from the Amylin, 3M, Barr Laboratories, Berlex Laboratories, Bristol-Myers Squibb, Byk Gulden, Eli Lilly, Endeavor Pharmaceuticals, Forest Laboratories, Neurocrine Biosciences, Novartis, Novo Nordisk, Organon, Pharmacia, Procter & Gamble, Pfizer, Roche, Sepracor, Solvay Pharmaceuticals, Wyeth, and Yamanouchi USA corporations and serves as a consultant for the Eli Lilly, Endeavor, Pfizer, Berlex, and Warner corporations.

This paper discusses therapies that are not approved by the US Food and Drug Administration for the use under discussion.

Author and Disclosure Information

Wulf H. Utian, MD, BCH, PhD
Department of Obstetrics and Gynecology, The Cleveland Clinic; Professor Emeritus, Case Western Reserve University; Executive Director, The North American Menopause Society

Address: Wulf H. Utian, MD, Executive Director, The North American Menopause Society, 5900 Landerbrook Drive, Cleveland, OH 44124; e-mail: [email protected]

The author has indicated that he has received research support from the Amylin, 3M, Barr Laboratories, Berlex Laboratories, Bristol-Myers Squibb, Byk Gulden, Eli Lilly, Endeavor Pharmaceuticals, Forest Laboratories, Neurocrine Biosciences, Novartis, Novo Nordisk, Organon, Pharmacia, Procter & Gamble, Pfizer, Roche, Sepracor, Solvay Pharmaceuticals, Wyeth, and Yamanouchi USA corporations and serves as a consultant for the Eli Lilly, Endeavor, Pfizer, Berlex, and Warner corporations.

This paper discusses therapies that are not approved by the US Food and Drug Administration for the use under discussion.

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 70(2)
Issue
Cleveland Clinic Journal of Medicine - 70(2)
Page Number
93-94
Page Number
93-94
Publications
Publications
Topics
Article Type
Display Headline
What are the key issues women face when ending hormone replacement therapy?
Display Headline
What are the key issues women face when ending hormone replacement therapy?
Sections
Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Alosetron (Lotronex) is back: Should I use it to treat my patients with irritable bowel syndrome?

Article Type
Changed
Fri, 11/02/2018 - 07:24
Display Headline
Alosetron (Lotronex) is back: Should I use it to treat my patients with irritable bowel syndrome?
Article PDF
Author and Disclosure Information

Bo Shen, MD
Department of Gastroenterology and Hepatology, The Cleveland Clinic

Edy E. Soffer, MD
Department of Gastroenterology and Hepatology, The Cleveland Clinic

Address: Edy E. Soffer, MD, Department of Gastroenterology and Hepatology, A30, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Issue
Cleveland Clinic Journal of Medicine - 70(1)
Publications
Topics
Page Number
64-65
Sections
Author and Disclosure Information

Bo Shen, MD
Department of Gastroenterology and Hepatology, The Cleveland Clinic

Edy E. Soffer, MD
Department of Gastroenterology and Hepatology, The Cleveland Clinic

Address: Edy E. Soffer, MD, Department of Gastroenterology and Hepatology, A30, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Author and Disclosure Information

Bo Shen, MD
Department of Gastroenterology and Hepatology, The Cleveland Clinic

Edy E. Soffer, MD
Department of Gastroenterology and Hepatology, The Cleveland Clinic

Address: Edy E. Soffer, MD, Department of Gastroenterology and Hepatology, A30, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 70(1)
Issue
Cleveland Clinic Journal of Medicine - 70(1)
Page Number
64-65
Page Number
64-65
Publications
Publications
Topics
Article Type
Display Headline
Alosetron (Lotronex) is back: Should I use it to treat my patients with irritable bowel syndrome?
Display Headline
Alosetron (Lotronex) is back: Should I use it to treat my patients with irritable bowel syndrome?
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Should everyone with a recent myocardial infarction receive a beta-blocker and an ACE inhibitor?

Article Type
Changed
Fri, 11/02/2018 - 07:04
Display Headline
Should everyone with a recent myocardial infarction receive a beta-blocker and an ACE inhibitor?
Article PDF
Author and Disclosure Information

John C. Hostetter, MD
Department of Cardiovascular Medicine, The Cleveland Clinic

Sasan Ghaffari, MD
Department of Cardiovascular Medicine, The Cleveland Clinic

Address: Sasan Ghaffari, MD, Department of Cardiovascular Medicine, F15, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Issue
Cleveland Clinic Journal of Medicine - 70(1)
Publications
Topics
Page Number
46-48
Sections
Author and Disclosure Information

John C. Hostetter, MD
Department of Cardiovascular Medicine, The Cleveland Clinic

Sasan Ghaffari, MD
Department of Cardiovascular Medicine, The Cleveland Clinic

Address: Sasan Ghaffari, MD, Department of Cardiovascular Medicine, F15, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Author and Disclosure Information

John C. Hostetter, MD
Department of Cardiovascular Medicine, The Cleveland Clinic

Sasan Ghaffari, MD
Department of Cardiovascular Medicine, The Cleveland Clinic

Address: Sasan Ghaffari, MD, Department of Cardiovascular Medicine, F15, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 70(1)
Issue
Cleveland Clinic Journal of Medicine - 70(1)
Page Number
46-48
Page Number
46-48
Publications
Publications
Topics
Article Type
Display Headline
Should everyone with a recent myocardial infarction receive a beta-blocker and an ACE inhibitor?
Display Headline
Should everyone with a recent myocardial infarction receive a beta-blocker and an ACE inhibitor?
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Which children and adults should receive the chickenpox vaccine?

Article Type
Changed
Mon, 12/17/2018 - 09:08
Display Headline
Which children and adults should receive the chickenpox vaccine?
Article PDF
Author and Disclosure Information

Camille Sabella, MD
Division of Pediatrics, Section of Pediatric Infectious Diseases, The Children’s Hospital at The Cleveland Clinic

Address: Camille Sabella, MD, Division of Pediatrics, Desk A120, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Issue
Cleveland Clinic Journal of Medicine - 69(12)
Publications
Topics
Page Number
1000-1001
Sections
Author and Disclosure Information

Camille Sabella, MD
Division of Pediatrics, Section of Pediatric Infectious Diseases, The Children’s Hospital at The Cleveland Clinic

Address: Camille Sabella, MD, Division of Pediatrics, Desk A120, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Author and Disclosure Information

Camille Sabella, MD
Division of Pediatrics, Section of Pediatric Infectious Diseases, The Children’s Hospital at The Cleveland Clinic

Address: Camille Sabella, MD, Division of Pediatrics, Desk A120, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 69(12)
Issue
Cleveland Clinic Journal of Medicine - 69(12)
Page Number
1000-1001
Page Number
1000-1001
Publications
Publications
Topics
Article Type
Display Headline
Which children and adults should receive the chickenpox vaccine?
Display Headline
Which children and adults should receive the chickenpox vaccine?
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

'Coach class thrombosis': Is the risk real? What do we tell our patients?

Article Type
Changed
Fri, 12/14/2018 - 10:58
Display Headline
'Coach class thrombosis': Is the risk real? What do we tell our patients?
Article PDF
Author and Disclosure Information

Daniel J. Brotman, MD
Section of Hospital and Preoperative Medicine, Department of General Internal Medicine, The Cleveland Clinic

Amir Jaffer, MD
Medical Director, Internal Medicine Preoperative Assessment Consultation and Treatment (IMPACT) Center, and the Anticoagulation Clinic, Department of General Internal Medicine, The Cleveland Clinic

Address: Amir Jaffer, MD, Department of General Internal Medicine, A72, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Issue
Cleveland Clinic Journal of Medicine - 69(11)
Publications
Topics
Page Number
832-833, 837
Sections
Author and Disclosure Information

Daniel J. Brotman, MD
Section of Hospital and Preoperative Medicine, Department of General Internal Medicine, The Cleveland Clinic

Amir Jaffer, MD
Medical Director, Internal Medicine Preoperative Assessment Consultation and Treatment (IMPACT) Center, and the Anticoagulation Clinic, Department of General Internal Medicine, The Cleveland Clinic

Address: Amir Jaffer, MD, Department of General Internal Medicine, A72, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Author and Disclosure Information

Daniel J. Brotman, MD
Section of Hospital and Preoperative Medicine, Department of General Internal Medicine, The Cleveland Clinic

Amir Jaffer, MD
Medical Director, Internal Medicine Preoperative Assessment Consultation and Treatment (IMPACT) Center, and the Anticoagulation Clinic, Department of General Internal Medicine, The Cleveland Clinic

Address: Amir Jaffer, MD, Department of General Internal Medicine, A72, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 69(11)
Issue
Cleveland Clinic Journal of Medicine - 69(11)
Page Number
832-833, 837
Page Number
832-833, 837
Publications
Publications
Topics
Article Type
Display Headline
'Coach class thrombosis': Is the risk real? What do we tell our patients?
Display Headline
'Coach class thrombosis': Is the risk real? What do we tell our patients?
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Should exercise electrocardiography be a routine part of the periodic health physical?

Article Type
Changed
Fri, 12/14/2018 - 10:18
Display Headline
Should exercise electrocardiography be a routine part of the periodic health physical?
Article PDF
Author and Disclosure Information

Anil Jain, MD
Department of General Internal Medicine, The Cleveland Clinic

Richard Lang, MD
Head, Section of Preventive Medicine; Chairman, Department of General Internal Medicine, The Cleveland Clinic

Address: Anil Jain, MD, Department of General Internal Medicine, A91, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Issue
Cleveland Clinic Journal of Medicine - 69(10)
Publications
Topics
Page Number
821-822
Sections
Author and Disclosure Information

Anil Jain, MD
Department of General Internal Medicine, The Cleveland Clinic

Richard Lang, MD
Head, Section of Preventive Medicine; Chairman, Department of General Internal Medicine, The Cleveland Clinic

Address: Anil Jain, MD, Department of General Internal Medicine, A91, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Author and Disclosure Information

Anil Jain, MD
Department of General Internal Medicine, The Cleveland Clinic

Richard Lang, MD
Head, Section of Preventive Medicine; Chairman, Department of General Internal Medicine, The Cleveland Clinic

Address: Anil Jain, MD, Department of General Internal Medicine, A91, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 69(10)
Issue
Cleveland Clinic Journal of Medicine - 69(10)
Page Number
821-822
Page Number
821-822
Publications
Publications
Topics
Article Type
Display Headline
Should exercise electrocardiography be a routine part of the periodic health physical?
Display Headline
Should exercise electrocardiography be a routine part of the periodic health physical?
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Is there a relationship between hypertension and cognitive function in older adults?

Article Type
Changed
Fri, 12/14/2018 - 06:44
Display Headline
Is there a relationship between hypertension and cognitive function in older adults?
Article PDF
Author and Disclosure Information

Rony Abou Jawde, MD
Department of Internal Medicine, The Cleveland Clinic

Barbara J. Messinger-Rapport, MD, PhD
Section of Geriatric Medicine, Department of Internal Medicine, The Cleveland Clinic

Address: Barbara J. Messinger-Rapport, MD, PhD, Section of Geriatric Medicine, A91, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected] 

Issue
Cleveland Clinic Journal of Medicine - 69(9)
Publications
Topics
Page Number
664-665, 669
Sections
Author and Disclosure Information

Rony Abou Jawde, MD
Department of Internal Medicine, The Cleveland Clinic

Barbara J. Messinger-Rapport, MD, PhD
Section of Geriatric Medicine, Department of Internal Medicine, The Cleveland Clinic

Address: Barbara J. Messinger-Rapport, MD, PhD, Section of Geriatric Medicine, A91, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected] 

Author and Disclosure Information

Rony Abou Jawde, MD
Department of Internal Medicine, The Cleveland Clinic

Barbara J. Messinger-Rapport, MD, PhD
Section of Geriatric Medicine, Department of Internal Medicine, The Cleveland Clinic

Address: Barbara J. Messinger-Rapport, MD, PhD, Section of Geriatric Medicine, A91, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected] 

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 69(9)
Issue
Cleveland Clinic Journal of Medicine - 69(9)
Page Number
664-665, 669
Page Number
664-665, 669
Publications
Publications
Topics
Article Type
Display Headline
Is there a relationship between hypertension and cognitive function in older adults?
Display Headline
Is there a relationship between hypertension and cognitive function in older adults?
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

'White coat hypertension'—should it be treated or not?

Article Type
Changed
Thu, 12/13/2018 - 14:59
Display Headline
'White coat hypertension'—should it be treated or not?
Article PDF
Author and Disclosure Information

Thomas Pickering, MD, DPhil
Michael and Zena Wiener Cardiovascular Institute, Mount Sinai School of Medicine, New York

Address: Thomas Pickering, MD, DPhil, Mount Sinai School of Medicine, 1 Gustave L. Levy Place, Box 1030, New York, NY 10029-6574

The author has indicated that he serves as a consultant for Lifeclinic.com and is on the speakers’ bureau of the Boehringer Ingelheim corporation.

Issue
Cleveland Clinic Journal of Medicine - 69(8)
Publications
Topics
Page Number
584-585
Sections
Author and Disclosure Information

Thomas Pickering, MD, DPhil
Michael and Zena Wiener Cardiovascular Institute, Mount Sinai School of Medicine, New York

Address: Thomas Pickering, MD, DPhil, Mount Sinai School of Medicine, 1 Gustave L. Levy Place, Box 1030, New York, NY 10029-6574

The author has indicated that he serves as a consultant for Lifeclinic.com and is on the speakers’ bureau of the Boehringer Ingelheim corporation.

Author and Disclosure Information

Thomas Pickering, MD, DPhil
Michael and Zena Wiener Cardiovascular Institute, Mount Sinai School of Medicine, New York

Address: Thomas Pickering, MD, DPhil, Mount Sinai School of Medicine, 1 Gustave L. Levy Place, Box 1030, New York, NY 10029-6574

The author has indicated that he serves as a consultant for Lifeclinic.com and is on the speakers’ bureau of the Boehringer Ingelheim corporation.

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 69(8)
Issue
Cleveland Clinic Journal of Medicine - 69(8)
Page Number
584-585
Page Number
584-585
Publications
Publications
Topics
Article Type
Display Headline
'White coat hypertension'—should it be treated or not?
Display Headline
'White coat hypertension'—should it be treated or not?
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media